These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3890532)

  • 1. Treatment of skin and soft tissue infections with imipenem/cilastatin.
    Fass RJ; Freimer EH; McCloskey RV
    Am J Med; 1985 Jun; 78(6A):110-2. PubMed ID: 3890532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of imipenem/cilastatin in the treatment of soft tissue infections.
    Marier RL
    Am J Med; 1985 Jun; 78(6A):140-4. PubMed ID: 3890534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imipenem/cilastatin in the treatment of obstetric and gynecologic infections: a review of worldwide experience.
    Sweet RL
    Rev Infect Dis; 1985; 7 Suppl 3():S522-7. PubMed ID: 3901216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meropenem versus imipenem/cilastatin in the treatment of hospitalized patients with skin and soft tissue infections.
    Nichols RL; Smith JW; Geckler RW; Wilson SE
    South Med J; 1995 Apr; 88(4):397-404. PubMed ID: 7716590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imipenem/cilastatin for pediatric infections in hospitalized patients.
    Nalin DR; Hart CB; Shih WJ; Aziz MA
    Scand J Infect Dis Suppl; 1987; 52():56-64. PubMed ID: 3331043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience with imipenem/cilastatin: analysis of a multicenter study.
    Shah PM
    Rev Infect Dis; 1985; 7 Suppl 3():S471-5. PubMed ID: 3901210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imipenem/cilastatin treatment of lower extremity skin and soft tissue infections in diabetics.
    Calandra GB; Raupp W; Brown KR
    Scand J Infect Dis Suppl; 1987; 52():15-9. PubMed ID: 3483286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imipenem/cilastatin in the treatment of obstetric and gynecologic infections.
    Berkeley AS; Freedman K; Hirsch J; Ledger WJ
    Am J Med; 1985 Jun; 78(6A):79-84. PubMed ID: 3859219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative clinical evaluation of imipenem/cilastatin vs. cefotaxime in treatment of severe bacterial infections.
    Stamboulian D; Argüello EA; Jasovich A; Villar O; Maglio F
    Rev Infect Dis; 1985; 7 Suppl 3():S458-62. PubMed ID: 3901208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imipenem/cilastatin in the treatment of serious bacterial infections.
    Chiodini PL; Geddes AM; Smith EG; Conlon CP; Farrell ID
    Rev Infect Dis; 1985; 7 Suppl 3():S490-5. PubMed ID: 3901212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter study of the clinical efficacy of imipenem/cilastatin for treatment of serious infections.
    Trumbore D; Pontzer R; Levison ME; Kaye D; Cynamon M; Liu C; Hinthorn DR; Tan JS; File TM
    Rev Infect Dis; 1985; 7 Suppl 3():S476-81. PubMed ID: 3931198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imipenem/cilastatin: general experience in a community hospital.
    Iannini PB; Kunkel MJ; Hilton E; Iannini GM
    Am J Med; 1985 Jun; 78(6A):122-6. PubMed ID: 3859211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Open trial of imipenem/cilastatin therapy for serious bacterial infections.
    Brooks RG; McCabe RE; Vosti KL; Remington JS
    Rev Infect Dis; 1985; 7 Suppl 3():S496-505. PubMed ID: 3901213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imipenem/cilastatin therapy of serious infections: a U.S. multicenter noncomparative trial.
    Calandra GB; Hesney M; Brown KR
    Clin Ther; 1985; 7(2):225-38. PubMed ID: 3886144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative clinical trial of imipenem-cilastatin (N-formimidoyl-thienamycin-dehydropeptidase inhibitor) and cefazolin.
    Marier RL; McCloskey RV; Dickenson G; Sanders CV; Aldridge KE; Hoffman T; Gutterman D; Janney A
    J Antimicrob Chemother; 1983 Dec; 12 Suppl D():133-9. PubMed ID: 6365873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fundamental and clinical studies of imipenem/cilastatin sodium in the field of obstetrics and gynecology. Study group of imipenem/cilastatin sodium in the field of obstetric and gynecological infections].
    Matsuda S; Suzuki M; Hasegawa Y; Ninomiya K; Shimizu T; Maeda Y; Ichinoe K; Makinoda S; Sato H; Sato H
    Jpn J Antibiot; 1986 Jun; 39(6):1626-55. PubMed ID: 3531568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intramuscular imipenem/cilastatin for treatment of mild and moderately severe bacterial infections.
    Keller CA; Villavicencio J; Ramirez C
    Scand J Infect Dis Suppl; 1987; 52():26-31. PubMed ID: 3483287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective randomized comparison of imipenem/cilastatin and cefotaxime for treatment of lung, soft tissue, and renal infections.
    Diaz-Mitoma F; Harding GK; Louie TJ; Thomson M; James M; Ronald AR
    Rev Infect Dis; 1985; 7 Suppl 3():S452-7. PubMed ID: 3901207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twice daily intramuscular imipenem/cilastatin in the treatment of skin and soft tissue infections.
    Sexton DJ; Wlodaver CG; Tobey LE; Yangco BG; Graziani AL; MacGregor RR
    Chemotherapy; 1991; 37 Suppl 2():26-30. PubMed ID: 1879184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imipenem/cilastatin in the treatment of osteomyelitis.
    MacGregor RR; Gentry LO
    Am J Med; 1985 Jun; 78(6A):100-3. PubMed ID: 3859207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.